EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Synflorix
Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed
![Synflorix Logo Synflorix Logo](/content/dam/global/hcpportal/en_CA/products/synflorix/images/synflorix-head.png)
EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed
Vaccine efficacy of SYNFLORIX in the ATP cohort
Adapted from Product Monograph1
* Double-blind study in healthy infants aged 6 to 16 weeks who were randomized to SYNFLORIX or hepatitis B control vaccine at 2, 4 and 6 months of age followed respectively by either SYNFLORIX or hepatitis A control vaccine at 15 to 18 months of age. The ATP cohort (n=5989) was defined as the group of participants immunized with at least the three-dose primary series.